Group-Based Intervention to Improve Mental Health and Adherence Among Youth Living With HIV in Low Resource Settings
Key facts
- Who runs it
- International Maternal Pediatric Adolescent AIDS Clinical Trials Group
- Where
- Botswana, Malawi, South Africa, and Zimbabwe8 sites in 4 countriesChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 484 people enrolled
- Started
- 6 Apr 2024
- Ended
- 5 Jun 2025
- Type of study
- Interventional, 4 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Youth TI-CBT Intervention Arm
- Youth Discussion Control Arm
- Caregiver TI-CBT Intervention Arm
- Caregiver Discussion Control Arm
- Record updated
- 22 May 2026
- Why it stopped
- The study was closed early due to funding issue
Who can take part
- Age
- 15 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- If of legal age to provide independent informed consent as determined by site Standard Operating Procedures (SOPs) and consistent with site IRB/EC policies and procedures: potential youth participant is willing and able to provide written informed consent for study participation
- If not of legal age to provide independent informed consent: Parent or guardian is willing and able to provide written informed consent for study participation and potential youth participant is willing and able to provide written informed assent for study participation
- Confirmed HIV-infection based on documented testing of two samples collected at different time points as documented in medical records or by confirmatory testing
- Age limit 15-19 years
- At screening, aware of his or her HIV infection, as confirmed by Investigator of Record or designee
- At screening, has been prescribed ART for a minimum of 24 weeks prior to screening based on medical record documentation
- At screening, meets at least one of the following indicators of moderate to severe mental health symptomology:; Patient Health Questionnaire-9 (PHQ-9) score ≥ 10; General Anxiety Disorder-7 (GAD-7) score ≥ 10; UCLA Post-Traumatic Stress Disorder-Reaction Index (UCLA PTSD-RI) score >= 35
- Caregiver, defined as a biological parent, legal guardian, or person who provides emotional, psychological and/or informational care to a youth taking part in the Randomized Trial, as identified by the youth, and for whom the youth has provided written permission to participate in the study
- Of legal age to provide independent consent and willing and able to provide written informed consent for study participation
Who cannot take part
- Prior participation in an IMPAACT 2016 Focus Group or Pilot Test
- Prior participation in an IMPAACT 2016 Focus Group or Pilot Test
- Any other condition, adverse social situation or cognitive impairment that, in the opinion of the site investigator, would preclude informed assent and informed consent, make study participation unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives
- At entry, participating in a study delivering a mental health or ART adherence intervention
This trial has no sites in United States.
It has sites in 4 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
IMPAACT 2016 was a multi-site, two-arm, individually randomized, controlled study to evaluate whether an Indigenous Leader Outreach Model (ILOM) of trauma-informed cognitive behavioral therapy (TI-CBT) delivered by Indigenous Youth Leaders (IYL) is associated with improved mental health outcomes and ART adherence among youth living with HIV in resource-limited settings. The intervention was adapted to the local context through advance conduct of focus groups and pilot testing.
The 4 groups in the trial
- Youth TI-CBT Intervention ArmTreatment being tested
For youth, the TI-CBT intervention arm consisted of six 2-hour TI-CBT group sessions led by Indigenous Youth Leaders (IYL) during weeks 1 to 8 and one 2-hour booster group session at 6-months. The TI-CBT Intervention was delivered in a group format. The TI-CBT Intervention arm had 15 groups with an average of 8.5 youth per group (range 6-11).
- Youth Discussion Control ArmExisting treatment, for comparison
For youth, the Discussion Control arm consisted of six 2-hour discussion group sessions led by IYL during weeks 1 to 8 and one 2-hour booster discussion group session at 6 months. The Discussion Control was delivered in a group format. The Discussion Control arm had 15 groups with an average of 8.4 youth per group (range 5-10).
- Caregiver TI-CBT Intervention ArmTreatment being tested
For caregivers, the TI-CBT Intervention arm consisted of two 2-hour TI-CBT group sessions on two separate weeks within 8 weeks of their youth's first group session and one 2-hour booster group session at 6-months led by adult study staff. The TI-CBT Intervention was delivered in group format. The TI-CBT Intervention arm had 15 groups with an average of 7.7 caregivers per group (range 5-10).
- Caregivers Discussion Control ArmExisting treatment, for comparison
For caregivers, the Discussion Control arm consisted of: two 2-hour discussion group sessions on two separate weeks within 8 weeks of their youth's first group session and one 2-hour booster discussion group session at 6 months led by adult study staff. The Discussion Control intervention was delivered in a group format. The Discussion Control arm had 15 groups with an average of 7.6 caregivers per group (range 3-10).
Treatment: Caregiver Discussion Control Arm
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- IMPAACT 2016 - Evaluating a Group-Based Intervention to Improve Mental Health and Antiretroviral Therapy (ART) Adherence Among Youth Living With HIV in Low Resource Settings
- Record updated
- 22 May 2026